PharmiWeb.com: The Heart of Life Sciences on the Web
WEBJOHNSON CITY, Tenn. and BURLINGTON, NC, (Sept. 9, 2024) -Ballad Health announced today it has reached agreement on a strategic collaboration with Labcorp, a global leader of innovative and comprehensive laboratory services, to provide outreach laboratory services across the Appalachian Highlands region. This agreement includes the sale of ...
Scientists develop artificial sugars to enhance disease diagnosis …
WEB1 day ago · Scientists have found a way to create artificial sugars that could lead to better ways to diagnose and treat diseases more accurately than ever before.Sugars play a crucial role in human health and disease, far beyond being just an energy source. Complex sugars called glycans coat all our cells and are essential for...
Gilead and Genesis Therapeutics Announce Strategic …
WEB3 days ago · Gilead Sciences, Inc. (Nasdaq: GILD) and Genesis Therapeutics, Inc. announced today that the companies have entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets.
Petros Pharmaceuticals Executes Successful Initial…
WEB3 days ago · Company is currently conducting larger scale comprehension test to confirm results in compliance with FDA discussions. NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over-the-counter ("OTC") drug development programs, today announced results of an ...
ABPI response to the Darzi Review: innovation must be at the …
WEB3 days ago · Responding to the Darzi Review, Richard Torbett, ABPI Chief Executive, said: “This hard-hitting report makes clear the huge pressure the NHS is under, but also highlights that it is innovation that can make the NHS more sustainable. “Turning the NHS around will require radical thinking, including investing in prevention, boosting NHS ...
Events - Events - PharmiWeb.com
WEB4 days ago · Events. 02-Sep-2024 - 07-Sep-2024. 9th Edition of International Conference on Dentistry and Oral Health (ICDO 2024) We kindly invite you to join the 9th International Conference on Dentistry and Oral Health (CE Accredited). The hybrid conference known as ICDO 2024 will take place virtually from September 02–04, 2024, in Madrid, Spain, and ...
Leqembi® (lecanemab) Authorised for Early Alzheimer’s Disease in …
WEBAug 29, 2024 · In Great Britain, lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer’s disease (AD) in adult patients that are apolipoprotein E ε4 (ApoE ε4)* heterozygotes or non-carriers1. Great Britain becomes the first country in Europe to authorise the medicine, which targets an underlying cause of AD1.
Today Stories - PharmiWeb.com
WEBEvotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery. WALTHAM, Mass, Sept. 05, 2024 – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and X-Chem, leader in DNA-encoded library (DEL) technology, today announced a collaboration agreement focused on accelerating early-stage drug discovery.
Explore Next-Generation Sequencing (NGS) Technology
WEBAug 22, 2024 · According to Prophecy Market Insights, the global NGS-based RNA-sequencing market size and share is projected to grow from USD 2.1 Billion in 2024 and is forecasted to reach USD 11.1 Billion by 2034, exhibiting a compound annual growth rate (CAGR) of 18.10% during the forecast period (2024 - 2034). The NGS-Based RNA-Sequencing Market is ...
Digital health tools are retooling the pharma industry
WEBMar 11, 2021 · Digital health tools as part of the clinical trial process allows for a greater connectivity to patients, able to capture feedback in real-time, and yields a greater field of data through direct input from patients themselves. Focusing on specific therapeutic areas. Instead of thinking about digital health as a wide-open concept, pharma is ...